CVSA vs EDU: Covista and New Oriental Education & Technology compared
The short version
From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.
- New Oriental Education & Technology is the larger company, worth $9.4B, about 2.1 times Covista.
- New Oriental Education & Technology grew revenue faster over the last year (+15.5% vs +9.7%).
- Covista keeps more of each dollar of revenue as operating profit (19.6% vs 11.4%).
- On earnings, Covista is the cheaper stock (18.7x vs 20.9x).
- New Oriental Education & Technology's price assumes faster free cash flow growth: about -2% a year, against -3% for Covista (reverse DCF).
Side by side
The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.
| Measure | CVSA | EDU |
|---|---|---|
| Market cap | $4.4B | $9.4B |
| Share price | $129.38 | $58.63 |
| Revenue (last fiscal year) | $2.0B | $5.7B |
| Free cash flow (last fiscal year) | $393M | $780M |
| Revenue growth, last year | +9.7% | +15.5% |
| Revenue growth per year, last 5 fiscal years | +9.0% | +16.2% |
| Operating margin | 19.6% | 11.4% |
| Net margin | 12.9% | 8.4% |
| Return on equity | 17.4% | 11.9% |
| P/E (trailing) | 18.7x | 20.9x |
| Price / free cash flow | 15.2x | 14.8x |
| EV / EBITDA | 10.8x | 5.70x |
| FCF growth the price implies | -2.7% | -1.7% |
| Dividend yield | — | 2.1% |
| Debt / equity | 1.08x | 1.12x |
| Fundamental grade | B | C |
| Superinvestors holding it | 4 | 2 |
| Insider purchases, last 12 months | 4 | 0 |
Results from SEC filings
Revenue and free cash flow by fiscal year, from each company's 10-K filings.
Covista
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2022 | $1.4B | -$20M | 5.6% |
| 2023 | $1.5B | $166M | 11.6% |
| 2024 | $1.6B | $247M | 13.7% |
| 2025 | $1.8B | $288M | 19.1% |
| 2026 | $2.0B | $393M | 19.6% |
New Oriental Education & Technology
| Year | Revenue | Free cash flow | Op. margin |
|---|---|---|---|
| 2022 | $3.1B | -$1.4B | -31.6% |
| 2023 | $3.0B | $828M | 6.3% |
| 2024 | $4.3B | $873M | 8.1% |
| 2025 | $4.9B | $655M | 8.7% |
| 2026 | $5.7B | $780M | 11.4% |
Where the revenue comes from
Covista · by segments, 2026
Walden$805M41%
Chamberlain$750M38%
Medical and Veterinary$399M20%
New Oriental Education & Technology · by segments, 2026
Educational services and test preparation courses$4.0B71%
Private label products and livestreaming e-commerce and other services$807M14%
Overseas Study Consulting Services$511M9%
Others$336M6%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CVSA in InvestinglyQuestions
Which is bigger, Covista or New Oriental Education & Technology?
New Oriental Education & Technology (EDU), at $9.4B against $4.4B.
Is CVSA or EDU cheaper?
By trailing P/E, Covista (18.7x) is cheaper than New Oriental Education & Technology (20.9x). A lower multiple can also mean the market expects less growth.
Which grows faster, CVSA or EDU?
New Oriental Education & Technology: revenue grew +15.5% over the last year, against +9.7%.
Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.